The genetics of Beh?et’s disease in a Chinese population

Abstract

Behçet’s disease is defined as a multisystemic inflammatory disease. Although the precise pathogenesis and etiology is still a mystery, accumulating evidence shows that genetic variants of immune-related genes have a profound influence on the development of Behçet’s disease. To explore the genetic factors for Behçet’s disease, our group investigated the association of Behçet’s disease with multiple immune response genes and has identified multiple Behçet’s disease-related immunoregulatory pathways in the Chinese Han population. A large number of gene polymorphisms were studied including STAT4, IL23R, CD40, CCR1/CCR3, STAT3, OPN, IL17, JAK2, MCP-1, CTLA4, PD-1, PD-L1, PD-L2, TGRBR3, CCR6, PTPN22, FCRL3, IRF5, SUMO4 and UBAC2. Significant associations were found between Behçet’s disease and STAT4, IL23R, CD40, CCR1/CCR3, STAT3, MCP-1, TGFBR3, FCRL3, SUMO4, UBAC2. These genetic predisposition studies support an important role for both lymphocyte differentiation as well as ubiquitination pathways. These findings are helpful in elucidating the pathogenesis of Behçet’s disease and hopefully will allow the development of novel treatment regimes.

Keywords

Behçet’s disease / SNPs / immune gene / genetic study

References

[1] Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med2008; 359(26): 2767-2777

[2] Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol2005; 50(4): 297-350

[3] James DG. Silk Route disease. Postgrad Med J1986; 62(725): 151-153

[4] Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, Ando K, Hijikata K, Izawa Y, Hayashi K, Numaga J, Fujino Y, Masuda K, Araie M. Comparison of patients with Behçet’s disease in the 1980s and 1990s. Ophthalmology2004; 111(4): 810-815

[5] Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, Zhu L, Ren Y, Klooster J, Kijlstra A. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res2005; 30(11): 943-948

[6] Escudier M, Bagan J, Scully C. Number VII Behçet’s disease (Adamantiades syndrome). Oral Dis2006; 12(2): 78-84

[7] Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, Tunç R, Urgancioğlu M, Dişçi R. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol2003; 42(10): 803-806

[8] Gül A. Behçet’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy2005; 4(1): 81-83

[9] Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, Kijlstra A. SUMO4 gene polymorphisms in Chinese Han patients with Behçet's disease. Clin Immunol2008; 129(1):170-175

[10] de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum2009; 61(10): 1287-1296

[11] Krause L, Köhler AK, Altenburg A, Papoutsis N, Zouboulis CC, Pleyer U, Stroux A, Foerster MH. Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet’s disease. Eye (Lond)2009; 23(5): 1182-1186

[12] Gül A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ. Evidence for linkage of the HLA-B locus in Behçet’s disease, obtained using the transmission disequilibrium test. Arthritis Rheum2001; 44(1): 239-240

[13] Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Shiina T, Nomura E, Onari K, Ohno S, Inoko H. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet’s disease. Tissue Antigens2001; 58(3): 181-184

[14] Li H, Yang P, Jiang Z, Hou S, Xie L. Lack of association of two polymorphisms of IRF5 with Behçet’s disease. Mol Vis2009; 15: 2018-2021

[15] Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, Merrill JT, James JA, Frank SG, Reams E, Brown EE, Gibson AW, Marion MC, Langefeld CD, Li QZ, Karp DR, Wakeland EK, Petri M, Ramsey-Goldman R, Reveille JD, Vilá LM, Alarcón GS, Kimberly RP, Harley JB, Edberg JC. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun2008; 9(3): 187-194

[16] Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E, Wiman AC, Vermeire S, Rutgeerts P, Belaiche J, Franchimont D, Van Gossum A, Bours V, Syvänen AC. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet2007; 16(24): 3008-3016

[17] Rueda B, Reddy MV, González-Gay MA, Balsa A, Pascual-Salcedo D, Petersson IF, Eimon A, Paira S, Scherbarth HR, Pons-Estel BA, González-Escribano MF, Alarcón-Riquelme ME, Martín J. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum2006; 54(12): 3815-3819

[18] Kristjansdottir G, Sandling JK, Bonetti A, Roos IM, Milani L, Wang C, Gustafsdottir SM, Sigurdsson S, Lundmark A, Tienari PJ, Koivisto K, Elovaara I, Pirttilä T, Reunanen M, Peltonen L, Saarela J, Hillert J, Olsson T, Landegren U, Alcina A, Fernández O, Leyva L, Guerrero M, Lucas M, Izquierdo G, Matesanz F, Syvänen AC. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet2008; 45(6): 362-369

[19] Zhang Q, Hou S, Jiang Z, Du L, Li F, Xiao X, Kijlstra A, Yang P. No association of PTPN22 polymorphisms with susceptibility to ocular Behçet’s disease in two Chinese Han populations. PLoS ONE2012; 7(3): e31230

[20] Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F, Madanat W, Kanawati C, Ghabra M, Murray PI, Wallace GR. The association of the PTPN22 620W polymorphism with Behçet’s disease. Ann Rheum Dis2007; 66(11): 1531-1533

[21] Du L, Yang P, Hou S, Zhou H, Kijlstra A. No association of CTLA-4 polymorphisms with susceptibility to Behçet disease. Br J Ophthalmol2009; 93(10): 1378-1381

[22] Zhang YJ, Xu WD, Duan ZH, Liu SS, Pan HF, Ye DQ.Lack of association between CTLA-4+49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis. Clin Exp Rheumatol2012<month>Sep</month><day>25</day>. [Epub ahead of print]

[23] Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E, Ghabra M, Murray PI, Wallace GR. CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens2008; 72(1): 49-53

[24] Ben Dhifallah I, Chelbi H, Braham A, Hamzaoui K, Houman MH. CTLA-4+49A/G polymorphism is associated with Behçet’s disease in a Tunisian population. Tissue Antigens2009; 73(3): 213-217

[25] Xu Y, Song G. The role of CD40-CD154 interaction in cell immunoregulation. J Biomed Sci2004; 11(4): 426-438

[26] Chen F, Hou S, Jiang Z, Chen Y, Kijlstra A, Rosenbaum JT, Yang P. CD40 gene polymorphisms confer risk of Behçet’s disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Rheumatology (Oxford)2012; 51(1): 47-51

[27] Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, Gianniny L, Korman BD, Padyukov L, Kurreeman FA, Chang M, Catanese JJ, Ding B, Wong S, van der Helm-van Mil AH, Neale BM, Coblyn J, Cui J, Tak PP, Wolbink GJ, Crusius JB, van der Horst-Bruinsma IE, Criswell LA, Amos CI, Seldin MF, Kastner DL, Ardlie KG, Alfredsson L, Costenbader KH, Altshuler D, Huizinga TW, Shadick NA, Weinblatt ME, de Vries N, Worthington J, Seielstad M, Toes RE, Karlson EW, Begovich AB, Klareskog L, Gregersen PK, Daly MJ, Plenge RM. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet2008; 40(10): 1216-1223

[28] Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol2008; 26(1): 677-704

[29] Meng Q, Guo H, Hou S, Jiang Z, Kijlstra A, Yang P. Lack of an association of PD-1 and its ligand genes with Behçet’s disease in a Chinese Han population. PLoS ONE2011; 6(10): e25345

[30] Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM, Alarcón-Riquelme M, Lau YL. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum2005; 52(4): 1058-1062

[31] Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Mäurer M, Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol2005; 58(1): 50-57

[32] Prokunina L, Castillejo-López C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdóttir H, Gröndal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jönssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcón-Segovia D, Steinsson K, Alarcón-Riquelme ME. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet2002; 32(4): 666-669

[33] Di Marzio P, Dai WW, Franchin G, Chan AY, Symons M, Sherry B. Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. Biochem Biophys Res Commun2005; 331(4): 909-916

[34] Saeki T, Naya A. CCR1 chemokine receptor antagonist. Curr Pharm Des2003; 9(15): 1201-1208

[35] Penido C, Castro-Faria-Neto HC, Vieira-de-Abreu A, Figueiredo RT, Pelled A, Martins MA, Jose PJ, Williams TJ, Bozza PT. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol2001; 25(6): 707-716

[36] Hou S, Xiao X, Li F, Jiang Z, Kijlstra A, Yang P. Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behçet’s disease susceptibility. Hum Genet2012<month>Jul</month><day>25</day>. [Epub ahead of print]

[37] Kirino Y, Bertsias G, Ombrello MJ, Ustek D, Satorius C, Le J, Mizuki N, Ishigatsubo Y, Seyahi E, Sacli FS, Gul A, Kastner DL, Remmers E.Genome-Wide Analysis of Imputed Genotypes Identifies Chemokine Receptor-1 CCR1) As a Novel Candidate Risk Locus in Behçet's Disease. Arthritis Rheum2011; 63(10): S946

[38] Hu K, Yang P, Jiang Z, Hou S, Du L, Li F. STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Behçet’s disease. Hum Immunol2010; 71(7): 723-726

[39] Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, Li F, Zhou Q, Ohno S, Chen R , Kijlstra A, Rosenbaum JT, Yang P. Genome-wide association study identifies susceptible locus in STAT4 for Behçet's disease in Han Chinese. Arthritis Rheum2012<month>Sep</month><day>22</day>.[Epub ahead of print]

[40] Chu M, Yang P, Hou S, Li F, Chen Y, Kijlstra A. Behçet’s disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms. Hum Immunol2011; 72(6): 525-529

[41] Jiang Z, Yang P, Hou S, Du L, Xie L, Zhou H, Kijlstra A. IL-23R gene confers susceptibility to Behçet’s disease in a Chinese Han population. Ann Rheum Dis2010; 69(7): 1325-1328

[42] Hu K, Hou S, Jiang Z, Kijlstra A, Yang P. JAK2 and STAT3 polymorphisms in a Han Chinese population with Behçet’s disease. Invest Ophthalmol Vis Sci 2012; 53(1): 538-541

[43] Shu Q, Yang P, Hou S, Li F, Chen Y, Du L, Jiang Z. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behçet’s disease in a Chinese Han population. Hum Immunol2010; 71(10): 988-991

[44] Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet2010; 42(8): 703-706

[45] Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O’Shea J, Wallace GR, Gadina M, Kastner DL, Gül A. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet’s disease. Nat Genet2010; 42(8): 698-702

[46] Hou S, Yang P, Du L, Jiang Z, Mao L, Shu Q, Zhou H, Kijlstra A. Monocyte chemoattractant protein-1-2518 A/G single nucleotide polymorphism in Chinese Han patients with ocular Behçet’s disease. Hum Immunol2010; 71(1): 79-82

[47] Yi X, Yang P, Du L, Jiang Z, Li F. There is no association of CCR6 polymorphisms with susceptibility to Behçet’s disease in two Chinese Han populations. Br J Ophthalmol2011; 95(11): 1603-1606

[48] Chen Y, Yang P, Li F, Hou S, Jiang Z, Shu Q, Kijlstra A. Association analysis of TGFBR3 gene with Vogt-Koyanagi-Harada disease and Behçet’s disease in the Chinese Han population. Curr Eye Res2012; 37(4): 312-317

[49] Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Behçet’s disease using a genome-wide association study. Arthritis Res Ther2009; 11(3): R66

[50] Hou S, Shu Q, Jiang Z, Chen Y, Li F, Chen F, Kijlstra A, Yang P. Replication study confirms the association between UBAC2 and Behçet’s disease in two independent Chinese sets of patients and controls. Arthritis Res Ther2012; 14(2): R70

[51] Sawalha AH, Hughes T, Nadig A, Yılmaz V, Aksu K, Keser G, Cefle A, Yazıcı A, Ergen A, Alarcón-Riquelme ME, Salvarani C, Casali B, Direskeneli H, Saruhan-Direskeneli G. A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet’s disease. Arthritis Rheum2011; 63(11): 3607-3612

[52] Fakhfakh Karray E, Bendhifallah I, Zakraoui L, Hamzaoui K. Association of small ubiquitin-like modifier 4 gene polymorphisms with rheumatoid arthritis in a Tunisian population. Clin Exp Rheumatol2011; 29(4): 751

[53] Park G, Kim HS, Choe JY, Kim SK. SUMO4 C438T polymorphism is associated with papulopustular skin lesion in Korean patients with Behçet’s disease. Rheumatol Int2012 ;32(10):3031-3037

[54] .Li K, Zhao M, Hou S, Du L, Kijlstra A, Yang P. Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet’s disease in a Chinese population with ophthalmic manifestations. Mol Vis2008; 14: 2136-2142

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg